Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Steven A Greenberg

Showing results (101-110 of 110) with videos related to

Pageof 11
Sort By:
You have reached the last page of results.This site can display upto 110 results.
Muscle & Nerve|March 18, 2009
Fast-twitch sarcomeric and glycolytic enzyme protein loss in inclusion body myositisKenneth C Parker, Sek Won Kong, Ronan J Walsh, et al.
Annals of Neurology|February 27, 2010
Interferon-stimulated gene 15 (ISG15) conjugates proteins in dermatomyositis muscle with perifascicular atrophyMohammad Salajegheh, Sek Won Kong, Jack L Pinkus, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|January 17, 2014
The plasma cell signature in autoimmune diseaseKatie Streicher, Christopher A Morehouse, Christopher J Groves, et al.
Pharmacoepidemiology and Drug Safety|July 19, 2012
Risk of Guillain-Barré syndrome after meningococcal conjugate vaccinationPriscilla Velentgas, Anthony A Amato, Rhonda L Bohn, et al.
The Journal of Investigative Dermatology|September 24, 2018
Advances in Cutaneous Lupus Erythematosus and Dermatomyositis: A Report from the 4th International Conference on Cutaneous Lupus Erythematosus-An Ongoing Need for International Consensus and CollaborationsJosef Symon S Concha, Aikaterini Patsatsi, Ann Marshak-Rothstein, et al.
The Lancet. Rheumatology|January 26, 2024
Sirolimus for treatment of patients with inclusion body myositis: a randomised, double-blind, placebo-controlled, proof-of-concept, phase 2b trialOlivier Benveniste, Jean-Yves Hogrel, Lisa Belin, et al.
Annals of the Rheumatic Diseases|June 20, 2024
Pathological autoantibody internalisation in myositisIago Pinal-Fernandez, Sandra Muñoz-Braceras, Maria Casal-Dominguez, et al.
Medrxiv : the Preprint Server for Health Sciences|February 5, 2024
Pathogenic autoantibody internalization in myositisIago Pinal-Fernandez, Sandra Muñoz-Braceras, Maria Casal-Dominguez, et al.
Nature|March 5, 2013
Mutations in prion-like domains in hnRNPA2B1 and hnRNPA1 cause multisystem proteinopathy and ALSHong Joo Kim, Nam Chul Kim, Yong-Dong Wang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 22, 2024
KLRG1 Cell Depletion as a Novel Therapeutic Strategy in Patients with Mature T-Cell Lymphoma SubtypesBimarzhan Assatova, Robert Willim, Christopher Trevisani, et al.
Pageof 11

Showing results (101-110 of 110) with videos related to

Sort By:
Pageof 11
You have reached the last page of results.This site can display upto 110 results.
Muscle & Nerve|March 18, 2009
Fast-twitch sarcomeric and glycolytic enzyme protein loss in inclusion body myositisKenneth C Parker, Sek Won Kong, Ronan J Walsh, et al.
Annals of Neurology|February 27, 2010
Interferon-stimulated gene 15 (ISG15) conjugates proteins in dermatomyositis muscle with perifascicular atrophyMohammad Salajegheh, Sek Won Kong, Jack L Pinkus, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|January 17, 2014
The plasma cell signature in autoimmune diseaseKatie Streicher, Christopher A Morehouse, Christopher J Groves, et al.
Pharmacoepidemiology and Drug Safety|July 19, 2012
Risk of Guillain-Barré syndrome after meningococcal conjugate vaccinationPriscilla Velentgas, Anthony A Amato, Rhonda L Bohn, et al.
The Journal of Investigative Dermatology|September 24, 2018
Advances in Cutaneous Lupus Erythematosus and Dermatomyositis: A Report from the 4th International Conference on Cutaneous Lupus Erythematosus-An Ongoing Need for International Consensus and CollaborationsJosef Symon S Concha, Aikaterini Patsatsi, Ann Marshak-Rothstein, et al.
The Lancet. Rheumatology|January 26, 2024
Sirolimus for treatment of patients with inclusion body myositis: a randomised, double-blind, placebo-controlled, proof-of-concept, phase 2b trialOlivier Benveniste, Jean-Yves Hogrel, Lisa Belin, et al.
Annals of the Rheumatic Diseases|June 20, 2024
Pathological autoantibody internalisation in myositisIago Pinal-Fernandez, Sandra Muñoz-Braceras, Maria Casal-Dominguez, et al.
Medrxiv : the Preprint Server for Health Sciences|February 5, 2024
Pathogenic autoantibody internalization in myositisIago Pinal-Fernandez, Sandra Muñoz-Braceras, Maria Casal-Dominguez, et al.
Nature|March 5, 2013
Mutations in prion-like domains in hnRNPA2B1 and hnRNPA1 cause multisystem proteinopathy and ALSHong Joo Kim, Nam Chul Kim, Yong-Dong Wang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 22, 2024
KLRG1 Cell Depletion as a Novel Therapeutic Strategy in Patients with Mature T-Cell Lymphoma SubtypesBimarzhan Assatova, Robert Willim, Christopher Trevisani, et al.
Pageof 11